Citic Securities Company Limited(600030)
About Longshine Technology Group Co.Ltd(300682)
Annual tracking report for 2021
Name of recommendation institution: Citic Securities Company Limited(600030) abbreviation of the recommended company: Longshine Technology Group Co.Ltd(300682)
Name of sponsor representative: Ji Ruonan Tel: 01060834526
Name of sponsor representative: Peng Jie Tel: 01060833022
1、 Overview of sponsor work
Project work content
1. Review of the company’s information disclosure
(1) Whether the company’s information disclosure documents are reviewed in time
(2) No one failed to review the company’s information disclosure documents in time
Number 2 Supervise the company’s establishment, improvement and effective implementation of rules and regulations (1) whether supervise the company to establish and improve rules and regulations (including
Including but not limited to preventing related parties from occupying the company’s resources
System, raised funds management system, internal control system, internal audit system and related party transaction system)
(2) Whether the company effectively implements relevant rules and regulations is
3. Supervision of raised funds
The recommendation institution inquires the company’s special account for raised funds every month (1) inquires the times of the company’s special account for raised funds, fund changes and the withdrawal and use of large amounts of funds
(2) Is the progress of the company’s fund-raising project consistent with the information
Consistency of disclosure documents 4 Corporate governance supervision
(1) The number of times of attending the general meeting of shareholders of the company as nonvoting delegates is not on-site, and the notices, proposals, resolutions and other documents of previous meetings have been reviewed
(2) The number of times of attending the company’s board of directors as nonvoting delegates is not on-site, and the notices, proposals, resolutions and other documents of previous meetings have been reviewed
(3) The number of times of attending the board of supervisors of the company as nonvoting delegates was not present, and the notices, proposals, resolutions and other documents of previous meetings have been reviewed
5. On site inspection
(1) Number of on-site inspections: 1
(2) Whether the on-site inspection report is reported in accordance with the provisions of the exchange
(3) main problems and rectification found in on-site inspection. No problems requiring rectification were found in the enterprise during on-site inspection.
6. Expression of independent opinions
(1) 8 times of expressing independent opinions
(2) Issues and conclusions involved in expressing non consenting opinions
See 7 Report the situation to the Institute (except for the on-site inspection report)
(1) No number of reports to the exchange
(2) The main contents of the report are none
(3) No progress or rectification of the reported items
8. Pay attention to the performance of duties
(1) Whether there are matters needing attention none
(2) Main contents of concerns none
(3) No progress or rectification of concerns
9. Whether the records and custody of the working papers of the recommendation business are in compliance
10. Training for listed companies
(1) Training times: 1 time
(2) Training date: December 10, 2021
Information disclosure of listed companies, management of raised funds, (3) the main contents of training are related party transactions, elimination of insider trading, trading of stocks after listing, etc
11. There is no other recommendation work that needs to be explained
2、 Problems found by the sponsor and measures taken
Problems and measures taken
1. Information disclosure none
2. Establishment and implementation of the company’s internal system
that ‘s ok
3. Operation of “three sessions” no
4. The controlling shareholder and actual controller have changed to none
move
5. Deposit and use of raised funds none
6. Related party transactions none
7. No external guarantee
8. Acquisition and sale of assets none
9. Other business categories and important matters
(including foreign investment and venture capital)
Capital, entrusted financial management, financial assistance, hedging, etc.)
10. The issuer or the intermediary hired by it is none
11. Cooperation of the institution with the recommendation work Others (including business environment and industry)
Business development, financial status and management statement none
III. implementation of commitments of the company and shareholders
Whether the commitments of the company and shareholders are fulfilled, the reasons for non fulfillment of commitments and the resolution measures
1. Restrictions on share circulation, voluntary lock-in and reduction are not applicable
Commitment
2. The commitment of share repurchase is not applicable
3. The commitment to stabilize the stock price is not applicable
4. The commitment to undertake compensation or compensation liability according to law is not applicable
5. It is not applicable to fill the diluted spot return due to initial public offering
Reported measures and commitments
6. The commitment of profit distribution policy is not applicable
7. The commitment to avoid horizontal competition is not applicable
8. It is not applicable to strengthen the constraints on the commitments of relevant responsible subjects
Measure IV. other matters
Description of report items
1. The change of sponsor representative and its reasons are not applicable
From January 1 to December 31, 2021, there are the following matters for which the CSRC (including its dispatched offices) and your exchange have taken regulatory measures against the sponsor or the recommended company:
1. On January 4, 2021, China Securities Regulatory Commission Zhejiang 2 During the reporting period, the CSRC and the bourse have taken regulatory measures against the Zhejiang Zhejiang Zhengyuan Zhihui Technology Co.Ltd(300645) branch sponsored by our company or the company sponsored by it, and
Rectification of zhengyuanzhi Technology Co., Ltd. (hereinafter referred to as “zhengyuanzhi”)
Hui “) issued the decision on Issuing warning letters to Zhejiang Zhejiang Zhengyuan Zhihui Technology Co.Ltd(300645) Technology Co., Ltd. and relevant personnel.
Regulatory measures: from January 2020 to July 2020, Zhejiang Zhengyuan Zhihui Technology Co.Ltd(300645) provided financial services to Zhejiang nipton Technology Co., Ltd
The company failed to timely perform the corresponding review procedures for the above matters and the obligation of information disclosure, which violated the provisions of articles 2, 3 and 30 of the measures for the administration of information disclosure of listed companies.
2. On January 8, 2021, Zhejiang regulatory bureau of China Securities Regulatory Commission issued the decision on Issuing warning letters to Panda Dairy Corporation(300898) Group Co., Ltd. and relevant personnel sponsored by our company (hereinafter referred to as Panda Dairy Corporation(300898) ). Regulatory measures: on October 29, 2020, Panda Dairy Corporation(300898) received 9 million yuan of government subsidies related to income, and failed to fulfill the obligation of information disclosure in time. The above-mentioned acts of the company and relevant personnel violate the relevant provisions of articles 2, 3, 30 and 31 of the measures for the administration of information disclosure of listed companies.
3. On January 29, 2021, Zhejiang regulatory bureau of China Securities Regulatory Commission issued the decision on ordering Zhejiang Kaishan Compressor Co., Ltd. to take corrective measures against Zhejiang Kaishan Compressor Co., Ltd. (hereinafter referred to as “Kaishan”). According to the regulatory measures, Zhejiang Bureau found Zhejiang Kaishan Compressor Co.Ltd(300257) problems in the on-site inspection: the performance accounting of regular reports in 2019 and 2020 is inaccurate; From 2019 to 2020, the company’s internal governance has the problems of non-standard use of funds, non-standard meeting process and non-independent personnel. The above acts violate the provisions of Article 2 of the measures for the administration of information disclosure of listed companies.
4. On March 2, 2021, Jiangxi regulatory bureau of China Securities Regulatory Commission issued the decision on ordering Boya Bio-Pharmaceutical Group Co.Ltd(300294) Pharmaceutical Group Co., Ltd., Liao Xinxi, Liang Xiaoming and fan Yiqin to take corrective measures against Boya Bio-Pharmaceutical Group Co.Ltd(300294) Pharmaceutical Group Co., Ltd., sponsored by our company (hereinafter referred to as “Boya biology”). According to the regulatory measures, upon investigation, Boya Bio-Pharmaceutical Group Co.Ltd(300294) has not fulfilled the review procedures and information disclosure obligations of related party transactions in time, failed to disclose the progress of major events and failed to fulfill the information disclosure obligations of related party transactions as required. It violates the relevant provisions of articles 2, 3, 32 and 48 of the measures for the administration of information disclosure of listed companies and Article 1 of the notice on Several Issues concerning the regulation of capital exchanges between listed companies and related parties and external guarantees of listed companies Boya Bio-Pharmaceutical Group Co.Ltd(300294) the chairman, general manager and then Secretary of the board of directors of the company failed to perform their duties
The bank has the obligation of diligence and responsibility, and is responsible for the above violations.
5. On August 26, 2021, Guangdong regulatory bureau of China Securities Regulatory Commission issued the decision on Issuing warning letters to By-Health Co.Ltd(300146) Co., Ltd. (hereinafter referred to as By-Health Co.Ltd(300146) ), Liang Yunchao, Lin Zhicheng, Wu Zhuoyi and Tang Jinyin recommended by our company. The regulatory measures pointed out that Thomson Beijian had the following violations in the acquisition of 100% equity of life – spacegroupptyltd and 46.67% equity of Guangzhou Thomson Baisheng Co., Ltd.: it failed to fully and prudently evaluate and disclose the major policy risks of the implementation of the e-commerce law; Fail to truthfully disclose the actual profit of the underlying assets and the related profit forecast
